Related Experiment Video
Updated: Nov 17, 2025

Culture and Co-Culture of Mouse Ovaries and Ovarian Follicles
Published on: March 17, 2015
Asciminib Mitigates DNA Damage Stress Signaling Induced by Cyclophosphamide in the Ovary
Luca Mattiello1, Giulia Pucci1, Francesco Marchetti1
1Department of Biology, University of Rome Tor Vergata, via della Ricerca Scientifica, 00133 Rome, Italy.
Abstract:
Cancer treatments can often adversely affect the quality of life of young women. One of the most relevant negative impacts is the loss of fertility. Cyclophosphamide is one of the most detrimental chemotherapeutic drugs for the ovary. Cyclophosphamide may induce the destruction of dormant follicles while promoting follicle activation and growth. Herein, we demonstrate the in vivo protective effect of the allosteric Bcr-Abl tyrosine kinase inhibitor Asciminib on signaling pathways activated by cyclophosphamide in mouse ovaries. We also provide evidence that Asciminib does not interfere with the cytotoxic effect of cyclophosphamide in Michigan Cancer Foundation (MCF)7 breast cancer cells. Our data indicate that concomitant administration of Asciminib mitigates the cyclophosphamide-induced ovarian reserve loss without affecting the anticancer potential of cyclophosphamide. Taken together, these observations are relevant for the development of effective ferto-protective adjuvants to preserve the ovarian reserve from the damaging effects of cancer therapies.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Drugs that Destabilize Microtubules
Meiosis II
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
Oogenesis
Drugs that Stabilize Microtubules

